National Other Liab from 2010 to 2024
| NHI Stock | USD 66.64 0.01 0.01% |
Other Liabilities | First Reported 2000-03-31 | Previous Quarter 5.3 M | Current Value 5.4 M | Quarterly Volatility 10.4 M |
Check National Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among National main balance sheet or income statement drivers, such as Depreciation And Amortization of 73.5 M, Interest Expense of 58.3 M or Total Revenue of 170.8 M, as well as many exotic indicators such as Price To Sales Ratio of 7.26, Dividend Yield of 0.0868 or PTB Ratio of 1.84. National financial statements analysis is a perfect complement when working with National Health Valuation or Volatility modules.
National | Other Liab |
Latest National Health's Other Liab Growth Pattern
Below is the plot of the Other Liab of National Health Investors over the last few years. It is National Health's Other Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in National Health's overall financial position and show how it may be relating to other accounts over time.
| Other Liab | 10 Years Trend |
|
Other Liab |
| Timeline |
National Other Liab Regression Statistics
| Arithmetic Mean | 23,584,284 | |
| Geometric Mean | 18,254,268 | |
| Coefficient Of Variation | 66.05 | |
| Mean Deviation | 11,506,211 | |
| Median | 22,449,000 | |
| Standard Deviation | 15,576,815 | |
| Sample Variance | 242.6T | |
| Range | 50.3M | |
| R-Value | (0.64) | |
| Mean Square Error | 155.9T | |
| R-Squared | 0.40 | |
| Significance | 0.01 | |
| Slope | (2,211,986) | |
| Total Sum of Squares | 3396.9T |
National Other Liab History
About National Health Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include National Health income statement, its balance sheet, and the statement of cash flows. National Health investors use historical funamental indicators, such as National Health's Other Liab, to determine how well the company is positioned to perform in the future. Although National Health investors may use each financial statement separately, they are all related. The changes in National Health's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on National Health's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on National Health Financial Statements. Understanding these patterns can help to make the right decision on long term investment in National Health. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Other Liabilities | 4.5 M | 4.3 M |
Currently Active Assets on Macroaxis
When determining whether National Health Investors offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Health Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Health Investors Stock:Check out the analysis of National Health Correlation against competitors. Note that the National Health Investors information on this page should be used as a complementary analysis to other National Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Complementary Tools for National Stock analysis
When running National Health's price analysis, check to measure National Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National Health is operating at the current time. Most of National Health's value examination focuses on studying past and present price action to predict the probability of National Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National Health's price. Additionally, you may evaluate how the addition of National Health to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |
Is National Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Health. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.14) | Dividend Share 3.6 | Earnings Share 3.05 | Revenue Per Share 7.368 | Quarterly Revenue Growth (0.12) |
The market value of National Health Investors is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Health's value that differs from its market value or its book value, called intrinsic value, which is National Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Health's market value can be influenced by many factors that don't directly affect National Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.